{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:11:55Z","timestamp":1791465115343,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T00:00:00Z","timestamp":1694908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC111-2314-B-038-006"],"award-info":[{"award-number":["NSTC111-2314-B-038-006"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC111-2628-B-038-019"],"award-info":[{"award-number":["NSTC111-2628-B-038-019"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC111-2811-B-038-022"],"award-info":[{"award-number":["NSTC111-2811-B-038-022"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC112-2811-B-038-044"],"award-info":[{"award-number":["NSTC112-2811-B-038-044"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115533","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T12:49:53Z","timestamp":1695473393000},"page":"115533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Para-toluenesulfonamide, a novel potent carbonic anhydrase inhibitor, improves hypoxia-induced metastatic breast cancer cell viability and prevents resistance to \u03b1PD-1 therapy in triple-negative breast cancer"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2411-426X","authenticated-orcid":false,"given":"Hsin-Yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-En","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Chieh","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Lee","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzong-Ming","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsui-Chin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2888-2618","authenticated-orcid":false,"given":"Shih-Min","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2023.115533_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20065156","article-title":"Estimating excess mortality due to prostate, breast, and uterus cancer during the COVID-19 pandemic in peru: a time series analysis","volume":"20","author":"Ram\u00edrez-Soto","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.biopha.2023.115533_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10549-021-06468-1","article-title":"Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system","volume":"191","author":"Tang","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.biopha.2023.115533_bib3","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA: A Cancer J. Clin."},{"key":"10.1016\/j.biopha.2023.115533_bib4","unstructured":"Breast Cancer Facts & Figures 2022\u20132024, Atlanta: American Cancer Society, Inc. 2022."},{"issue":"1035","key":"10.1016\/j.biopha.2023.115533_bib5","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130676","article-title":"Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response","volume":"87","author":"McKeown","year":"2014","journal-title":"Br. J. Radiol."},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2023.115533_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1634\/theoncologist.13-S3-21","article-title":"Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis","volume":"13","author":"Vaupel","year":"2008","journal-title":"oncologist"},{"issue":"4","key":"10.1016\/j.biopha.2023.115533_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040686","article-title":"Detection of hypoxia in cancer models: significance, challenges, and advances","volume":"11","author":"Godet","year":"2022","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.biopha.2023.115533_bib8","first-page":"577","article-title":"Tumour acidosis: from the passenger to the driver's seat, nature reviews","volume":"17","author":"Corbet","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2023.115533_bib9","first-page":"49","article-title":"The role of hypoxia-induced factor 1\u03b1 in breast cancer","volume":"5","author":"Peir\u00f3","year":"2019","journal-title":"J. Cancer Metastas-.-. Treat."},{"issue":"1","key":"10.1016\/j.biopha.2023.115533_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115533_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159473","article-title":"Cross-talk between HIF and PD-1\/PD-L1 pathways in carcinogenesis and therapy","volume":"132","author":"Shurin","year":"2022","journal-title":"J. Clin. Investig."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115533_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10555-018-09777-y","article-title":"Tumor pH and metastasis: a malignant process beyond hypoxia","volume":"38","author":"Thews","year":"2019","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2023.115533_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040992","article-title":"Hypoxia-driven immune escape in the tumor microenvironment","volume":"9","author":"Vito","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2023.115533_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","article-title":"Carbonic anhydrase IX and acid transport in cancer","volume":"122","author":"Becker","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2023.115533_bib15","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1111\/jcmm.15252","article-title":"CA9 transcriptional expression determines prognosis and tumour grade in tongue squamous cell carcinoma patients","volume":"24","author":"Guan","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.115533_bib16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3892\/ijo.2017.4098","article-title":"Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelial\u2011mesenchymal transition in hepatocellular carcinoma","volume":"51","author":"Hyuga","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2023.115533_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1087270","article-title":"Carbonic anhydrase IX-related tumoral hypoxia predicts worse prognosis in breast cancer: a systematic review and meta-analysis","volume":"10","author":"Numprasit","year":"2023","journal-title":"Front. Med."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115533_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastas-.-. Rev."},{"key":"10.1016\/j.biopha.2023.115533_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fphys.2013.00271","article-title":"The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration","volume":"4","author":"Csaderova","year":"2013","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115533_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051045","article-title":"Cancer drug development of carbonic anhydrase inhibitors beyond the active site","volume":"23","author":"Singh","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115533_bib21","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3389\/fphar.2018.01223","article-title":"Para-toluenesulfonamide induces anti-tumor activity through akt-dependent and -independent mTOR\/p70S6K pathway: roles of lipid raft and cholesterol contents","volume":"9","author":"Hsu","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"19","key":"10.1016\/j.biopha.2023.115533_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195967","article-title":"Autophagic activation and decrease of plasma membrane cholesterol contribute to anticancer activities in non-small cell lung cancer","volume":"26","author":"Hsu","year":"2021","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.biopha.2023.115533_bib23","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/CAD.0000000000000283","article-title":"Para-toluenesulfonamide induces tongue squamous cell carcinoma cell death through disturbing lysosomal stability","volume":"26","author":"Liu","year":"2015","journal-title":"Anti-Cancer Drugs"},{"issue":"4","key":"10.1016\/j.biopha.2023.115533_bib24","first-page":"472","article-title":"Antitumor effect of para-toluenesulfonamide against lung cancer xenograft in a mouse model","volume":"5","author":"Gao","year":"2013","journal-title":"J. Thorac. Dis."},{"issue":"17","key":"10.1016\/j.biopha.2023.115533_bib25","article-title":"Effects of para-toluenesulfonamide on canine melanoma xenotransplants in a BALB\/c nude mouse model","volume":"12","author":"Lin","year":"2022","journal-title":"Anim.: Open Access J. MDPI"},{"key":"10.1016\/j.biopha.2023.115533_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2019.00107","article-title":"In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis","volume":"7","author":"Pijuan","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"25","key":"10.1016\/j.biopha.2023.115533_bib27","doi-asserted-by":"crossref","first-page":"20882","DOI":"10.1021\/acsomega.9b01474","article-title":"Molecular and cellular response of co-cultured cells toward cobalt chloride (CoCl(2))-induced hypoxia","volume":"4","author":"Tripathi","year":"2019","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.biopha.2023.115533_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054325","article-title":"Carbonic anhydrase IX in tumor tissue and plasma of breast cancer patients: reliable biomarker of hypoxia and prognosis","volume":"24","author":"Rezuchova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115533_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijo.2015.3253","article-title":"CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer","volume":"48","author":"Chu","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"16","key":"10.1016\/j.biopha.2023.115533_bib30","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.7150\/jca.18457","article-title":"Breast cancer cell line classification and its relevance with breast tumor subtyping","volume":"8","author":"Dai","year":"2017","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2023.115533_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00280-014-2635-1","article-title":"Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells","volume":"75","author":"Ivanova","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115533_bib32","article-title":"Transcriptome analysis of breast cancer cell line exposed to hypoxia-mimetic chemical CoCl2 or hypoxic microenvironment","volume":"20","author":"de Amorim","year":"2020","journal-title":"Gene Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.115533_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jat.3749","article-title":"The use of cobalt chloride as a chemical hypoxia model","volume":"39","author":"Mu\u00f1oz-S\u00e1nchez","year":"2019","journal-title":"J. Appl. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115533_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s40659-019-0221-z","article-title":"CoCl(2) simulated hypoxia induce cell proliferation and alter the expression pattern of hypoxia associated genes involved in angiogenesis and apoptosis","volume":"52","author":"Rana","year":"2019","journal-title":"Biol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115533_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040606","article-title":"The oxygen-generating calcium peroxide-modified magnetic nanoparticles attenuate hypoxia-induced chemoresistance in triple-negative breast cancer","volume":"13","author":"Cheng","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.biopha.2023.115533_bib36","first-page":"2771","article-title":"Opposite response to hypoxia by breast cancer cells between cell proliferation and cell migration: a clue from microRNA expression profile","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2023.115533_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041520","article-title":"Disruption of the Complex between GAPDH and Hsp70 Sensitizes C6 Glioblastoma Cells to Hypoxic Stress","volume":"22","author":"Mikeladze","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2023.115533_bib38","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1073\/pnas.040554897","article-title":"Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro","volume":"97","author":"Parkkila","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.biopha.2023.115533_bib39","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.bmc.2013.03.068","article-title":"Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma","volume":"21","author":"Said","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2023.115533_bib40","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: an update","volume":"89","author":"Kim","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115533_bib41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2013.11.019","article-title":"p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents","volume":"344","author":"Sui","year":"2014","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.biopha.2023.115533_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072346","article-title":"Understanding MAPK signaling pathways in apoptosis","volume":"21","author":"Yue","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115533_bib43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.freeradbiomed.2021.10.015","article-title":"PRL-3 dephosphorylates p38 MAPK to promote cell survival under stress","volume":"177","author":"Shi","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.115533_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2023.115533_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002088","article-title":"Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck","volume":"9","author":"Zandberg","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2023.115533_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.01.003","article-title":"Distinct immune cell populations define response to Anti-PD-1 monotherapy and Anti-PD-1\/Anti-CTLA-4 combined therapy","volume":"35","author":"Gide","year":"2019","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.biopha.2023.115533_bib47","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/2326-6066.CIR-18-0657","article-title":"Targeting hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically","volume":"7","author":"Chafe","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biopha.2023.115533_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.lungcan.2016.05.012","article-title":"Effects of para\u2013toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: a multi-center, non-randomized, single-arm, open-label trial","volume":"98","author":"Li","year":"2016","journal-title":"Lung Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:32:05Z","timestamp":1776461525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223013318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":48,"alternative-id":["S0753332223013318"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115533","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Para-toluenesulfonamide, a novel potent carbonic anhydrase inhibitor, improves hypoxia-induced metastatic breast cancer cell viability and prevents resistance to \u03b1PD-1 therapy in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115533"}}